Format

Send to

Choose Destination
Mayo Clin Proc. 1998 Aug;73(8):777-9.

Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.

Author information

1
Department of Pediatric and Adolescent Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.

Abstract

Protein-losing enteropathy (PLE) is a serious complication of the Fontan operation and is associated with pronounced mortality. Medical management of PLE has been only partially successful. A recent report noted dramatic improvement in patients with PLE within 3 weeks of subcutaneous administration of heparin. We report a case of reversal of PLE with resolution of clinical symptoms and normalization of serum albumin, total protein, and fecal alpha1-antitrypsin values after several months of heparin treatment. Our findings substantiate those recently reported but suggest that reversal of PLE may necessitate more than a few weeks of heparin therapy.

PMID:
9703306
DOI:
10.4065/73.8.777
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center